Venous stenoses in patients who undergo hemodialysis: Treatment with self- expandable endovascular stents

S. F. Quinn, E. S. Schuman, L. Hall, G. F. Gross, Barry Uchida, B. A. Standage, Josef Rosch, K. Ivancev

Research output: Contribution to journalArticle

86 Citations (Scopus)

Abstract

During a 32-month period, 25 modified self-expandable endovascular stents were placed in 20 hemodialysis access sites to treat 21 stenoses and four occlusions in 19 patients. All stenoses were initially dilated with a high- pressure balloon. The initial success rate was 90% (18 of 20 access sites). The stents were patent from 0 to 960 days (mean duration of follow-up, 309 days). At 2 years follow-up, the patency rates were as follows: primary, 25%; secondary, 34%; and tertiary, 42%. The morbidity rate associated with this procedure was 15% (three of 20 sites); the mortality rate, 5% (one of 19 patients). All five complications (graft or native-vein thrombosis [n = 2], nerve deficits [n = 2], and death secondary to sepsis [n = 1]) occurred in three patients early in the study, before the use of prophylactic antibiotics and refinements in technique. The best results occurred in patients in whom the stenosis or occlusion affected a large vein that had no acute angle and was away from venous confluences such as the femoral and iliac regions.

Original languageEnglish (US)
Pages (from-to)499-504
Number of pages6
JournalRadiology
Volume183
Issue number2
StatePublished - 1992

Fingerprint

Stents
Renal Dialysis
Pathologic Constriction
Veins
Therapeutics
Thigh
Sepsis
Thrombosis
Anti-Bacterial Agents
Morbidity
Transplants
Pressure
Mortality

Keywords

  • Interventional procedures
  • Prostheses
  • Veins, innominate
  • Veins, stenosis or obstruction

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology

Cite this

Quinn, S. F., Schuman, E. S., Hall, L., Gross, G. F., Uchida, B., Standage, B. A., ... Ivancev, K. (1992). Venous stenoses in patients who undergo hemodialysis: Treatment with self- expandable endovascular stents. Radiology, 183(2), 499-504.

Venous stenoses in patients who undergo hemodialysis : Treatment with self- expandable endovascular stents. / Quinn, S. F.; Schuman, E. S.; Hall, L.; Gross, G. F.; Uchida, Barry; Standage, B. A.; Rosch, Josef; Ivancev, K.

In: Radiology, Vol. 183, No. 2, 1992, p. 499-504.

Research output: Contribution to journalArticle

Quinn, SF, Schuman, ES, Hall, L, Gross, GF, Uchida, B, Standage, BA, Rosch, J & Ivancev, K 1992, 'Venous stenoses in patients who undergo hemodialysis: Treatment with self- expandable endovascular stents', Radiology, vol. 183, no. 2, pp. 499-504.
Quinn SF, Schuman ES, Hall L, Gross GF, Uchida B, Standage BA et al. Venous stenoses in patients who undergo hemodialysis: Treatment with self- expandable endovascular stents. Radiology. 1992;183(2):499-504.
Quinn, S. F. ; Schuman, E. S. ; Hall, L. ; Gross, G. F. ; Uchida, Barry ; Standage, B. A. ; Rosch, Josef ; Ivancev, K. / Venous stenoses in patients who undergo hemodialysis : Treatment with self- expandable endovascular stents. In: Radiology. 1992 ; Vol. 183, No. 2. pp. 499-504.
@article{03cf73f227ed437ca6d6ab97bcb5bb3d,
title = "Venous stenoses in patients who undergo hemodialysis: Treatment with self- expandable endovascular stents",
abstract = "During a 32-month period, 25 modified self-expandable endovascular stents were placed in 20 hemodialysis access sites to treat 21 stenoses and four occlusions in 19 patients. All stenoses were initially dilated with a high- pressure balloon. The initial success rate was 90{\%} (18 of 20 access sites). The stents were patent from 0 to 960 days (mean duration of follow-up, 309 days). At 2 years follow-up, the patency rates were as follows: primary, 25{\%}; secondary, 34{\%}; and tertiary, 42{\%}. The morbidity rate associated with this procedure was 15{\%} (three of 20 sites); the mortality rate, 5{\%} (one of 19 patients). All five complications (graft or native-vein thrombosis [n = 2], nerve deficits [n = 2], and death secondary to sepsis [n = 1]) occurred in three patients early in the study, before the use of prophylactic antibiotics and refinements in technique. The best results occurred in patients in whom the stenosis or occlusion affected a large vein that had no acute angle and was away from venous confluences such as the femoral and iliac regions.",
keywords = "Interventional procedures, Prostheses, Veins, innominate, Veins, stenosis or obstruction",
author = "Quinn, {S. F.} and Schuman, {E. S.} and L. Hall and Gross, {G. F.} and Barry Uchida and Standage, {B. A.} and Josef Rosch and K. Ivancev",
year = "1992",
language = "English (US)",
volume = "183",
pages = "499--504",
journal = "Radiology",
issn = "0033-8419",
publisher = "Radiological Society of North America Inc.",
number = "2",

}

TY - JOUR

T1 - Venous stenoses in patients who undergo hemodialysis

T2 - Treatment with self- expandable endovascular stents

AU - Quinn, S. F.

AU - Schuman, E. S.

AU - Hall, L.

AU - Gross, G. F.

AU - Uchida, Barry

AU - Standage, B. A.

AU - Rosch, Josef

AU - Ivancev, K.

PY - 1992

Y1 - 1992

N2 - During a 32-month period, 25 modified self-expandable endovascular stents were placed in 20 hemodialysis access sites to treat 21 stenoses and four occlusions in 19 patients. All stenoses were initially dilated with a high- pressure balloon. The initial success rate was 90% (18 of 20 access sites). The stents were patent from 0 to 960 days (mean duration of follow-up, 309 days). At 2 years follow-up, the patency rates were as follows: primary, 25%; secondary, 34%; and tertiary, 42%. The morbidity rate associated with this procedure was 15% (three of 20 sites); the mortality rate, 5% (one of 19 patients). All five complications (graft or native-vein thrombosis [n = 2], nerve deficits [n = 2], and death secondary to sepsis [n = 1]) occurred in three patients early in the study, before the use of prophylactic antibiotics and refinements in technique. The best results occurred in patients in whom the stenosis or occlusion affected a large vein that had no acute angle and was away from venous confluences such as the femoral and iliac regions.

AB - During a 32-month period, 25 modified self-expandable endovascular stents were placed in 20 hemodialysis access sites to treat 21 stenoses and four occlusions in 19 patients. All stenoses were initially dilated with a high- pressure balloon. The initial success rate was 90% (18 of 20 access sites). The stents were patent from 0 to 960 days (mean duration of follow-up, 309 days). At 2 years follow-up, the patency rates were as follows: primary, 25%; secondary, 34%; and tertiary, 42%. The morbidity rate associated with this procedure was 15% (three of 20 sites); the mortality rate, 5% (one of 19 patients). All five complications (graft or native-vein thrombosis [n = 2], nerve deficits [n = 2], and death secondary to sepsis [n = 1]) occurred in three patients early in the study, before the use of prophylactic antibiotics and refinements in technique. The best results occurred in patients in whom the stenosis or occlusion affected a large vein that had no acute angle and was away from venous confluences such as the femoral and iliac regions.

KW - Interventional procedures

KW - Prostheses

KW - Veins, innominate

KW - Veins, stenosis or obstruction

UR - http://www.scopus.com/inward/record.url?scp=0026747694&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026747694&partnerID=8YFLogxK

M3 - Article

C2 - 1561357

AN - SCOPUS:0026747694

VL - 183

SP - 499

EP - 504

JO - Radiology

JF - Radiology

SN - 0033-8419

IS - 2

ER -